Medical Marijuana Market by Product (Dried Form and Extract Form), by Application (Pain Management, Seizure, and Others), and by Distribution Channel (Retail Pharmacy and E-Commerce): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017 - 2024

Description

The report covers the forecast and analysis for the medical marijuana market on a global and regional level. The study provides historical data from2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the medical marijuana market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the medical marijuana market on a global level.

In order to give the users of this report a comprehensive view of the medical marijuana market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses the market attractiveness analysis, wherein product, application, and distribution channel, and regional segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions and mergers, new product launches, agreements, partnerships, collaborations, and joint ventures, research and development, and regional expansion of major participants involved in the market on a global and regional basis. 

The study provides a decisive view of the medical marijuana market by segmenting the market based on product, application, distribution channel, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further bifurcation into major countries.

Some of the leading players in medical marijuana market include MedReleaf Corporation, GW Pharmaceuticals PLC, Canopy Growth Corporation, Green Relief Inc., Aurora Cannabis Inc., Aphria Incorporation, Cannabis Sativa, INC., Medical Marijuana, The Peace Naturals Project, and Insys Therapeutics, Inc.

This report segments the global medical marijuana market as follows:

Global Medical Marijuana Market: Product Segment Analysis

• Dried Form
• Extract Form

Global Medical Marijuana Market: Application Segment Analysis

• Pain Management
• Seizure
• Others

Global Medical Marijuana Market: Distribution Channel Segment Analysis

• Retail Pharmacy
• E-Commerce

Global Medical Marijuana Market: Regional Segment Analysis

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• The Middle East and Africa

Table Of Content

• Chapter 1. Introduction
  • 1.1. Report description and scope
  • 1.2. Research scope
  • 1.3. Research methodology
    • 1.3.1. Market research process
    • 1.3.2. Market research methodology
•  
• Chapter 2. Executive Summary
  • 2.1. Global medical marijuana market,2017 - 2024 (USD Billion)
  • 2.2. Global medical marijuana market: snapshot
•  
• Chapter 3. Medical Marijuana Market- Dynamics
  • 3.1. Introduction
  • 3.2. Market Drivers
    • 3.2.1. Global medical marijuana market drivers: impact analysis
    • 3.2.2. Increasing prevalence of conditions that require medical marijuana
    • 3.2.3. Rising geriatric population in need of treatment for chronic diseases
    • 3.2.4. Growing Awareness about Application of Marijuana
    • 3.2.5. Rising Prevalence of Chronic Pain
    • 3.2.6. Increasing number of Medical Marijuana Clubs
  • 3.3. Market Restraints
    • 3.3.1. Global medical marijuana market restraints: impact analysis
    • 3.3.2. The high cost associated with Medical Marijuana
    • 3.3.3. Stringent Regulation
  • 3.4. Opportunities
    • 3.4.1. Huge untapped market
    • 3.4.2. Government Support
  • 3.5. Porter’s five forces analysis
    • 3.5.1. Bargaining power of suppliers
    • 3.5.2. Bargaining power of buyers
    • 3.5.3. The threat from new entrants
    • 3.5.4. The threat from new substitutes
    • 3.5.5. Degree of competition
  • 3.6. Market Attractiveness Analysis
    • 3.6.1. Market attractiveness analysis, by product segment
    • 3.6.2. Market attractiveness analysis, by Application Segment
    • 3.6.3. Market attractiveness analysis, by Distribution Channel segment
    • 3.6.4. Market attractiveness analysis, by regional segment
•  
• Chapter 4. Global Medical Marijuana Market- Competitive Landscape
  • 4.1. Company market share analysis
    • 4.1.1. Global medical marijuana market: company market share, 2017
  • 4.2. Strategic development
    • 4.2.1. Acquisitions & mergers
    • 4.2.2. New therapy launch
    • 4.2.3. Agreements, partnerships, collaborations and joint ventures
    • 4.2.4. Research and development and regional expansion
  • 4.3. Price trend analysis
  • 4.4. Regulatory Framework
•  
• Chapter 5. Global Medical Marijuana Market- Product Segment Analysis
  • 5.1. Global medical marijuana market: product overview
    • 5.1.1. Global medical marijuana market revenue share, by product, 2017 and 2024
  • 5.2. Dried form
    • 5.2.1. Global medical marijuana market for Dried form, 2017 - 2024 (USD Billion)
  • 5.3. Extract Form
    • 5.3.1. Global medical marijuana market for Extract Form,2017 - 2024(USD Billion)
•  
• Chapter 6. Global Medical Marijuana Market - ApplicationSegment Analysis
  • 6.1. Global medical marijuana market: Application overview
    • 6.1.1. Global medical marijuana market revenue share, by Application, 2017 and 2024
  • 6.2. Pain Management
    • 6.2.1. Global medical marijuana market for Pain Management, 2017 - 2024(USD Billion)
  • 6.3. Seizure
    • 6.3.1. Global medical marijuana market for Seizure, 2017 - 2024 (USD Billion)
  • 6.4. Other applications
    • 6.4.1. Global medical marijuana market for Other applications, 2017 - 2024 (USD Billion)
•  
• Chapter 7. Global Medical Marijuana Market- Distribution Channel Segment Analysis
  • 7.1. Global medical marijuana market: Distribution Channel overview
    • 7.1.1. Global medical marijuana market revenue share, by Distribution Channel, 2017 and 2024
  • 7.2. Retail Pharmacy
    • 7.2.1. Global medical marijuana market for Retail Pharmacy, 2017 - 2024(USD Billion)
  • 7.3. E-Commerce
    • 7.3.1. Global medical marijuana market for e-Commerce, 2017 - 2024 (USD Billion)
•  
• Chapter 8. Global Medical Marijuana Market- Regional Segment Analysis
  • 8.1. Global medical marijuana market: regional overview
    • 8.1.1. Global medical marijuana market revenue share, by region, 2017 and 2024
  • 8.2. North America
    • 8.2.1. North American medical marijuana market revenue, by product, 2017 - 2024(USD Billion)
    • 8.2.2. North American medical marijuana market revenue, by Application, 2017 - 2024 (USD Billion)
    • 8.2.3. North American medical marijuana market revenue, by Distribution Channel, 2017 - 2024 (USD Billion)
    • 8.2.4. The U.S.
      • 8.2.4.1. The U.S. medical marijuana market revenue, by product, 2017 - 2024(USD Billion)
      • 8.2.4.2. The U.S.medical marijuana market revenue, by Application, 2017 - 2024 (USD Billion)
      • 8.2.4.3. The U.S. medical marijuana market revenue, by Distribution Channel, 2017 - 2024 (USD Billion)
    • 8.2.5. Canada
      • 8.2.5.1. Canada medical marijuana market revenue, by product, 2017 - 2024(USD Billion)
      • 8.2.5.2. Canada medical marijuana market revenue, by Application, 2017 - 2024 (USD Billion)
      • 8.2.5.3. Canada medical marijuana market revenue, by Distribution Channel, 2017 - 2024 (USD Billion)
  • 8.3. Europe
    • 8.3.1. Europe medical marijuana market revenue, by product, 2017 - 2024(USD Billion)
    • 8.3.2. Europe medical marijuana market revenue, by Application, 2017 - 2024 (USD Billion)
    • 8.3.3. Europe medical marijuana market revenue, by Distribution Channel, 2017 - 2024 (USD Billion)
    • 8.3.4. U.K.
      • 8.3.4.1. U.K. medical marijuana market revenue, by product, 2017 - 2024(USD Billion)
      • 8.3.4.2. U.K.medical marijuana market revenue, by Application, 2017 - 2024 (USD Billion)
      • 8.3.4.3. U.K. medical marijuana market revenue, by Distribution Channel, 2017 - 2024 (USD Billion)
    • 8.3.5. Germany
      • 8.3.5.1. Germany medical marijuana market revenue, by product, 2017 - 2024(USD Billion)
      • 8.3.5.2. German medical marijuana market revenue, by Application, 2017 - 2024 (USD Billion)
      • 8.3.5.3. Germany medical marijuana market revenue, by Distribution Channel, 2017 - 2024 (USD Billion)
    • 8.3.6. France
      • 8.3.6.1. France medical marijuana market revenue, by product, 2017 - 2024(USD Billion)
      • 8.3.6.2. France medical marijuana market revenue, by Application, 2017 - 2024 (USD Billion)
      • 8.3.6.3. France medical marijuana market revenue, by Distribution Channel, 2017 - 2024 (USD Billion)
    • 8.3.7. Italy
      • 8.3.7.1. Italy medical marijuana market revenue, by product, 2017 - 2024 (USD Billion)
      • 8.3.7.2. Italy medical marijuana market revenue, by Application, 2017 - 2024 (USD Billion)
      • 8.3.7.3. Italy medical marijuana market revenue, by Distribution Channel, 2017 - 2024 (USD Billion)
    • 8.3.8. Czech Republic
      • 8.3.8.1. Czech Republic medical marijuana market revenue, by product, 2017 - 2024 (USD Billion)
      • 8.3.8.2. Czech Republic medical marijuana market revenue, by Application, 2017 - 2024 (USD Billion)
      • 8.3.8.3. Czech Republic medical marijuana market revenue, by Distribution Channel, 2017 - 2024 (USD Billion)
    • 8.3.9. Netherlands
      • 8.3.9.1. Netherlands medical marijuana market revenue, by product, 2017 - 2024 (USD Billion)
      • 8.3.9.2. Netherlands medical marijuana market revenue, by Application, 2017 - 2024 (USD Billion)
      • 8.3.9.3. Netherlands medical marijuana market revenue, by Distribution Channel, 2017 - 2024 (USD Billion)
    • 8.3.10. Rest of Europe
      • 8.3.10.1. Rest of Europe medical marijuana market revenue, by product, 2017 - 2024(USD Billion)
      • 8.3.10.2. Rest of Europe medical marijuana market revenue, by Application, 2017 - 2024 (USD Billion)
      • 8.3.10.3. Rest of Europe medical marijuana market revenue, by Distribution Channel, 2017 - 2024 (USD Billion)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific medical marijuana market revenue, by product, 2017 - 2024(USD Billion)
    • 8.4.2. Asia Pacific medical marijuana market revenue, by Application, 2017 - 2024 (USD Billion)
    • 8.4.3. Asia Pacific medical marijuana market revenue, by Distribution Channel, 2017 - 2024 (USD Billion)
    • 8.4.4. Australia
      • 8.4.4.1. Australia medical marijuana market revenue, by product, 2017 - 2024(USD Billion)
      • 8.4.4.2. Australia medical marijuana market revenue, by Application, 2017 - 2024 (USD Billion)
      • 8.4.4.3. Australia medical marijuana market revenue, by Distribution Channel, 2017 - 2024 (USD Billion)
    • 8.4.5. Rest of Asia Pacific
      • 8.4.5.1. Rest of Asia Pacific medical marijuana market revenue, by product, 2017 - 2024(USD Billion)
      • 8.4.5.2. Rest of Asia Pacific medical marijuana market revenue, by Application, 2017 - 2024 (USD Billion)
      • 8.4.5.3. Rest of Asia Pacific medical marijuana market revenue, by Distribution Channel, 2017 - 2024 (USD Billion)
  • 8.5. Latin America
    • 8.5.1. Latin America medical marijuana market revenue, by product, 2017 - 2024(USD Billion)
    • 8.5.2. LatinAmericamedical marijuana market revenue, by Application, 2017 - 2024 (USD Billion)
    • 8.5.3. Latin America medical marijuana market revenue, by Distribution Channel, 2017 - 2024 (USD Billion)
    • 8.5.4. Argentina
      • 8.5.4.1. Argentina medical marijuana market revenue, by product, 2017 - 2024(USD Billion)
      • 8.5.4.2. Argentina medical marijuana market revenue, by Application, 2017 - 2024 (USD Billion)
      • 8.5.4.3. Argentina medical marijuana market revenue, by Distribution Channel, 2017 - 2024 (USD Billion)
    • 8.5.5. Chile
      • 8.5.5.1. Chile medical marijuana market revenue, by product, 2017 - 2024 (USD Billion)
      • 8.5.5.2. Chile medical marijuana market revenue, by Application, 2017 - 2024 (USD Billion)
      • 8.5.5.3. Chile medical marijuana market revenue, by Distribution Channel, 2017 - 2024 (USD Billion)
    • 8.5.6. Peru
      • 8.5.6.1. Peru medical marijuana market revenue, by product, 2017 - 2024 (USD Billion)
      • 8.5.6.2. Peru medical marijuana market revenue, by Application, 2017 - 2024 (USD Billion)
      • 8.5.6.3. Peru medical marijuana market revenue, by Distribution Channel, 2017 - 2024 (USD Billion)
    • 8.5.7. Rest of Latin America
      • 8.5.7.1. Rest of Latin America medical marijuana market revenue, by product, 2017 - 2024(USD Billion)
      • 8.5.7.2. Rest of Latin America medical marijuana market revenue, by Application, 2017 - 2024 (USD Billion)
      • 8.5.7.3. Rest of Latin America medical marijuana market revenue, by Distribution Channel, 2017 - 2024 (USD Billion)
  • 8.6. The Middle East and Africa
    • 8.6.1. The Middle East and Africa medical marijuana market revenue, by product, 2017 - 2024(USD Billion)
    • 8.6.2. The Middle East and Africa carts market revenue, by Application, 2017 - 2024 (USD Billion)
    • 8.6.3. The Middle East and Africa medical marijuana market revenue, by Distribution Channel, 2017 - 2024 (USD Billion)
    • 8.6.4. Israel
      • 8.6.4.1. Israel medical marijuana market revenue, by product, 2017 - 2024 (USD Billion)
      • 8.6.4.2. Israel medical marijuana market revenue, by Application, 2017 - 2024 (USD Billion)
      • 8.6.4.3. Israel medical marijuana market revenue, by Distribution Channel, 2017 - 2024 (USD Billion)
•  
• Chapter 9. Company Profile
  • 9.1. MedReleaf Corporation
    • 9.1.1. Overview
    • 9.1.2. Financials
    • 9.1.3. Product portfolio
    • 9.1.4. Business strategy
    • 9.1.5. Recent developments
  • 9.2. GW Pharmaceuticals PLC
    • 9.2.1. Overview
    • 9.2.2. Financials
    • 9.2.3. Product portfolio
    • 9.2.4. Business strategy
    • 9.2.5. Recent developments
  • 9.3. Canopy Growth Corporation
    • 9.3.1. Overview
    • 9.3.2. Financials
    • 9.3.3. Product portfolio
    • 9.3.4. Business strategy
    • 9.3.5. Recent developments
  • 9.4. Green Relief Inc.
    • 9.4.1. Overview
    • 9.4.2. Financials
    • 9.4.3. Product portfolio
    • 9.4.4. Business strategy
    • 9.4.5. Recent developments
  • 9.5. Aurora Cannabis Inc
    • 9.5.1. Overview
    • 9.5.2. Financials
    • 9.5.3. Product portfolio
    • 9.5.4. Business strategy
    • 9.5.5. Recent developments
  • 9.6. Aphria Incorporation
    • 9.6.1. Overview
    • 9.6.2. Financials
    • 9.6.3. Product portfolio
    • 9.6.4. Business strategy
    • 9.6.5. Recent developments
  • 9.7. Cannabis Sativa, INC.
    • 9.7.1. Overview
    • 9.7.2. Financials
    • 9.7.3. Product portfolio
    • 9.7.4. Business strategy
    • 9.7.5. Recent developments
  • 9.8. Medical Marijuana
    • 9.8.1. Overview
    • 9.8.2. Financials
    • 9.8.3. Product portfolio
    • 9.8.4. Business strategy
    • 9.8.5. Recent developments
  • 9.9. The Peace Naturals Project
    • 9.9.1. Overview
    • 9.9.2. Financials
    • 9.9.3. Product portfolio
    • 9.9.4. Business strategy
    • 9.9.5. Recent developments
  • 9.10. Insys Therapeutics, Inc.
    • 9.10.1. Overview
    • 9.10.2. Financials
    • 9.10.3. Product portfolio
    • 9.10.4. Business strategy
    • 9.10.5. Recent developments

Methodology

Free Analysis

Marijuana is a greenish-gray color mixture of dried flowers of cannabis sativa. Medical marijuana is in its inception phase in the medical sector. The chemical characteristics of medical marijuana have their usage in the treatment of various diseases, such as mental disorders, chronic pain, cancer, etc. Marijuana for medicinal uses is steadily finding acceptance in the society globally, which, in turn, is fuelling the expansion of medical marijuana market on a global scale.

Currently, medical marijuana is in its initial phase in the medicinal healthcare industry. It is a revolutionary product that is garnering mass acceptance globally, where Chinese remedies still use such plants and have a long history associated with marijuana. Medical marijuana has the potential to create a huge impact on the healthcare industry to cure cases that are not treatable by traditional medicines. Medical marijuana is basically common marijuana plant used to obtain an authentic composition of cannabinoids required for manufacturing the product needed for medicinal use.

The medical marijuana market is segmented based on product, application, and distribution channel. By product, the medical marijuana market is bifurcated into dried form and extracts form. Based on application, the market is segmented into pain management, seizure, and others. By distribution channel, the market covers retail pharmacy and e-commerce.

North America accounted for the largest share in the medical marijuana market in 2017 and is likely to register the highest CAGR over the forecast timeframe. The legalization of cannabis in the U.S. for medical uses is one of the key factors contributing to the high growth rate of the medical marijuana market in the region. Moreover, Canada’s move to legalize recreational marijuana is expected to boost market growth in North America in the upcoming years. Europe accounted for the second position in terms of revenue in the global medical marijuana market. 

Some of the leading players in medical marijuana market include MedReleaf Corporation, GW Pharmaceuticals PLC, Canopy Growth Corporation, Green Relief Inc., Aurora Cannabis Inc., Aphria Incorporation, Cannabis Sativa, INC., Medical Marijuana, The Peace Naturals Project, and Insys Therapeutics, Inc. The growing competition among the key players operating in the market, owing to rising acceptance of marijuana for medical use and new product launches by the companies operating in the market are expected to propel the growth of the global market in the future. For instance, on October 4, 2018, the Medical Marijuana Inc., the first publicly traded marijuana company in the U.S., launched its new product, Real Scientific Canada crossways Canada via Canadian formulation and extraction company Salvation Botanicals, Ltd. Moreover, on October 17, 2018, the company launched various cannabis products, which includes internationally-recognized Real Scientific Hemp Oil, which was first Cannabidiol (CBD) product line in the U.S. to receive import permits in Mexico, Brazil, and Paraguay, and to be sold over state lines.